Mymetics Corporation (MYMX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jul 11, 2025
Mymetics Market Cap
Mymetics has a market cap or net worth of $46.00 as of August 25, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
46.00
Enterprise Value
n/a
Revenue
564.14K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 15, 2001, Mymetics's market cap has decreased from 64.67M to 46.00, a decrease of -100.00%. That is a compound annual growth rate of -44.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 46.00 | -99.99% |
| Dec 28, 2023 | 486.01K | -94.67% |
| Dec 30, 2022 | 9.11M | -9.09% |
| Dec 31, 2021 | 10.02M | -58.23% |
| Dec 31, 2020 | 24.00M | 97.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |